Characterization of the MSMEG_2631 gene (mmp) encoding a multidrug and toxic compound extrusion (MATE) family protein in Mycobacterium smegmatis and exploration of its polyspecific nature using biolog phenotype microarray

Journal of Bacteriology

Volumn 195, Issue 7, 2013, Pages 1610-1621

  Mishra, Mukti Nath ^a   Daniels, Lacy ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BACTERIAL DNA; BACTERIAL PROTEIN; BLEOMYCIN; CAPREOMYCIN; CETYLPYRIDINIUM SALT; KANAMYCIN; MULTIDRUG AND TOXIC COMPOUND EXTRUSION PROTEIN; PHLEOMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; CONTROLLED STUDY; DNA DAMAGE; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE DELETION; MEMBRANE TRANSPORT PROTEINS; MICROARRAY ANALYSIS; MYCOBACTERIUM SMEGMATIS; OPERON; PHENOTYPE; PROMOTER REGIONS, GENETIC; SUBSTRATE SPECIFICITY; TRANSCRIPTION INITIATION SITE;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM SMEGMATIS;

EID: 84875524631     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.01724-12     Document Type: Article

References (62)

1. WHO (World Health Organization). 2011. WHO report 2011: global tuberculosis control. http://www.who.int/tb/publications/global_report /2011/gtbr11_full.pdf.
2. Stewart GR, Robertson BD, Young DB. 2003. Tuberculosis: a problem with persistence. Nat. Rev. Microbiol. 1:97-105.
3. Zhang Y. 2004. Persistent and dormant tubercle bacilli and latent tuberculosis. Front. Biosci. 9:1136-1156.
4. Li XZ, Zhang L, Nikaido H. 2004. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48:2415-2423.
5. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, Moghazeh SL, Eisner W, Daniel TM, Kaplan MH, Crawford JT, Musser JM, Kreiswirth BN. 1996. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 275: 487-489.
6. Banerjee A, Dubnau E, Quémard A, Balasubramian V, Um KS, Wilson T, Collins D, de Lisle G, Jacobs WR. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263: 227-230.
7. Dessen A, Quémard A, Blanchard JS, Jacobs WR, Jr, Sacchettini JC. 1995. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267:1638 -1641.
8. Honore N, Cole ST. 1994. Streptomycin resistance in mycobacteria. Antimicrob. Agents Chemother. 38:238-242.
9. Morris S, Bai GH, Suffys P, Portillogomez L, Fairchok M, Rouse D. 1995. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis. 171:954-960.
10. Rouse DA, Li ZM, Bai GH, Morris SL. 1995. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39:2472-2477.
11. Pretorius GS, Van Helden PD, Sirgel FA, Eisenach KD, Victor TC. 1995. Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare. Antimicrob. Agents Chemother. 39:2276 -2281.
12. Victor TC, Pretorius GS, Felix JV, Jordaan AM, Van Helden PD, Eisenach KD. 1996. katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis are not infrequent. Antimicrob. Agents Chemother. 40:1572. (Letter to the editor.)
13. Hogan D, Kolter R. 2002. Why are bacteria refractory to antimicrobials? Curr. Opin. Microbiol. 5:472-477.
14. Normark BH, Normark S. 2002. Evolution and spread of antibiotic resistance. J. Intern. Med. 252:91-106.
15. Brennan PJ. 2003. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis 83:91-97.
16. Niederweis M. 2003. Mycobacterial porins-new channel proteins in unique outer membranes. Mol. Microbiol. 49:1167-1177.
17. De Rossi E, Ainsa JA, Riccardi G. 2006. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol. Rev. 30:36 -52.
18. Brown MH, Paulsen IT, Skurray RA. 1999. The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol. Microbiol. 31:394-395.
19. Kuroda T, Tsuchiya T. 2009. Multidrug efflux transporters in the MATE family. Biochim. Biophys. Acta 1794:763-768.
20. Omote H, Hiasa M, Matsumoto T, Otsuka M, Moriyama Y. 2006. The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations. Trends Pharmacol. Sci. 27:587-593.
21. Morita M, Shitan N, Sawada K, Van Montagu MCE, Inzé D, Rischer H, Goossens A, Oksman-Caldentey KM, Moriyama Y, Yazaki K. 2009. Vacuolar transport of nicotine is mediated by a multidrug and toxic compound extrusion (MATE) transporter in Nicotiana tabacum. Proc. Natl. Acad. Sci. U. S. A. 106:2447-2452.
22. Becker ML, Visser LE, van Schaik RHN, Hofman A, Uitterlinden AG, Stricker BH. 2009. Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. Diabetes 58:745-749.
23. Tsuda M, Terada T, Mizuno T, Katsura T, Shimakura J, Inui K. 2009. Targeted disruption of the multidrug and toxin extrusion 1 (Mate 1) gene in mice reduces renal secretion of metformin. Mol. Pharmacol. 75:1280- 1286.
24. Kaatz GW, McAleese F, Seo SM. 2005. Multidrug resistance in Staphy-lococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob. Agents Chemother. 49: 1857-1864.
25. McAleese F, Petersen P, Ruzin A, Dunman PM, Murphy E, Projan SJ, Bradford PA. 2005. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob. Agents Chemother. 49:1865-1871.
26. Moriyama Y, Hiasa M, Matsumoto T, Omote H. 2008. Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics. Xenobiotica 38:1107-1118.
27. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
28. Quandt J, Hynes MF. 1993. Versatile suicide vectors which allow direct selection for gene replacement in Gram-negative bacteria. Gene 127:15-21.
29. Stephan J, Stemmer V, Niederweis M. 2004. Consecutive gene deletions in Mycobacterium smegmatis using the yeast FLP recombinase. Gene 343: 181-190.
30. Kapsa I, Ehrt S, Seeber S, Schnappinger D, Martin C, Riley LW, Niederweis M. 2001. Energy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatis. Gene 278:115-124.
31. Linn T, Pierre RS. 1990. Improved vector system for constructing transcriptional fusions that ensures independent translation of lacZ. J. Bacteriol. 172:1077-1084.
32. Ren Q, Chen K, and, Paulsen IT. 2007. TransportDB: a comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels. Nucleic Acids Res. 35:D274-D279.
33. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596 -1599.
34. Stothard P. 2000. The Sequence Manipulation Suite: JavaScript programs for analyzing and formatting protein and DNA sequences. Biotechniques 28:1102-1104.
35. Zhou L, Lei X-H, Bochner BR, Wanner BL. 2003. Phenotype MicroArray analysis of Escherichia coli K-12 mutants with deletions of all two-component systems. J. Bacteriol. 185:4956-4972.
36. Long F, Rouquette-Loughlin C, Shafer WM, Yu EW. 2008. Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli. Antimicrob. Agents Chemother. 52:3052-3060.
37. Miller, JH. 1972. Experiments in molecular genetics, p 352-355. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
38. +-driven multidrug efflux pump. J. Bacteriol. 182: 6694-6697.
39. +-coupled multidrug efflux pumps from Vibrio parahaemolyticus. J. Bacteriol. 184:572-576.
40. +-driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium. FEMS Microbiol. Lett. 203:235-239.
41. +-coupled multidrug efflux pump, from Vibrio cholerae non-O1. Microbiol. Immunol. 47:419-427.
42. Xu XJ, Su XZ, Morita Y, Kuroda T, Mizushima T, Tsuchiya T. 2003. Molecular cloning and characterization of the HmrM multidrug efflux pump from Haemophilus influenza. Microbiol. Immunol. 47:937-943.
43. +-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa. J. Bacteriol. 186: 262-265.
44. +-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob. Agents Chemother. 49: 4362-4364.
45. Bergman NH, Passalacqua KD, Hanna PC, Qin ZS. 2007. Operon prediction for sequenced bacterial genomes without experimental information. Appl. Environ. Microbiol. 73:846-854.
46. Li XZ, Livermore DM, Nikaido H. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa-resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob. Agents Chemother. 38: 1732-1741.
47. Nikaido H. 2001. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin. Cell Dev. Biol. 12:215-223.
48. Ryan BM, Dougherty TJ, Beaulieu D, Chuang J, Dougherty BA, Barrett JF. 2001. Efflux in bacteria: what do we really know about it? Expert Opin. Investig. Drugs 10:1409 -1422.
49. Zgurskaya HI, Nikaido H. 2000. Multidrug resistance mechanisms: drug efflux across two membranes. Mol. Microbiol. 37:219 -225.
50. Li XZ, Nikaido H, Poole K. 1995. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39: 1948-1953.
51. Mata MT, Baquero F, Perez-Diaz JC. 2000. A multidrug efflux transporter in Listeria monocytogenes. FEMS Microbiol. Lett. 187:185-188.
52. Li XZ, Nikaido H. 2009. Efflux-mediated drug resistance in bacteria: an update. Drugs 69:1555-1623.
53. Takiff HE, Cimino M, Musso MC, Weisbrod T, Martinez R, Delgado MB, Salazar L, Bloom BR, Jacobs WR, Jr. 1996. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc. Natl. Acad. Sci. U. S. A. 93:362-366.
54. Eckert B, Beck CF. 1989. Overproduction of transposon Tn10-encoded tetracycline resistance protein results in cell death and loss of membrane potential. J. Bacteriol. 171:3557-3559.
55. Hickman RK, McMurry LM, Levy SB. 1990. Overproduction and purification of the Tn10-specified inner membrane tetracycline resistance protein Tet with fusions to β-galactosidase. Mol. Microbiol. 4:1241-1251.
56. Krueger JH, Elledge SJ, Walker GC. 1983. Isolation and characterization of Tn5 insertion mutations in the lexA gene of Escherichia coli. J. Bacteriol. 153:1368 -1378.
57. Mortier-Barriere I, De Saizieu A, Claverys JP, Martin B. 1998. Competence- specific induction of recA is required for full recombination proficiency during transformation in Streptococcus pneumoniae. Mol. Microbiol. 27:159-170.
58. Brown DG, Swanson JK, Allen C. 2007. Two host-induced Ralstonia solanacearum genes, acrA and dinF, encode multidrug efflux pumps and contribute to bacterial wilt virulence. Appl. Environ. Microbiol. 73:2777- 2786.
59. Dianov G, Sedgwick B, Daly G, Olsson M, Lovett S, Lindahl T. 1994. Release of 5=-terminal deoxyribose-phosphate residues from incised abasic sites in DNA by the Escherichia coli RecJ protein. Nucleic Acids Res. 22:993-998.
60. Wakamatsu T, Kim K, Uemura Y, Nakagawa N, Kuramitsu S, Masui R. 2011. Role of RecJ-like protein with 5=-3= exonuclease activity in oligo(deoxy) nucleotide degradation. J. Biol. Chem. 286:2807-2816.
61. Burse A, Weingart H, Ullrich MS. 2004. NorM, an Erwinia amylovora multidrug efflux pump involved in in vitro competition with other epiphytic bacteria. Appl. Environ. Microbiol. 70:693-703.
62. Dridi L, Tankovic J, Petit JC. 2004. CdeA of Clostridium difficile, a new multidrug efflux transporter of the MATE family. Microb. Drug Resist. 10:191-196.